Patel Sushil bought RVMD
June 29, 2026 · Form 4 insider transaction
Patel Sushil bought 2,955 shares of Revolution Medicines, Inc. at $37.54 per share, a transaction worth $110.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,955
Price
$37.54
Total value
$110.9K
InsiderPatel Sushil
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after27,236
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026.; Includes 1,191 restricted stock units.